| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +30K | 47.6% | $6.98 | +$209K |
| Sells | 5 | -33K | 52.4% | $4.85 | -$160K |
| Net | -4 | -3K | -4.8% | +$49.4K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Mark J. Foley | CEO, Director | $10.4M | +$209K | +2.05% | Jun 30, 2024 |
| Aubrey Rankin | Director | $4.26M | Mar 15, 2022 | ||
| Dwight Moxie | Clo & Gc | $1.7M | -$41K | -2.35% | Mar 15, 2024 |
| Tobin Schilke | Cfo | $1.51M | -$47.2K | -3.04% | Jun 30, 2024 |
| Abhay Joshi | COO, President of R&D | $902K | Mar 15, 2022 | ||
| Dustin S. Sjuts | President | $845K | -$46.4K | -5.21% | Mar 15, 2024 |
| David Hollander | CMO & Global Therapeutics Lead | $438K | -$16.3K | -3.59% | Nov 18, 2024 |
| Erica Jordan | Chief Commercial Officer | $437K | -$9.1K | -2.04% | Apr 16, 2024 |
| Angus C. Russell | Director | $196K | May 1, 2024 | ||
| Julian S. Gangolli | Director | $172K | May 1, 2024 | ||
| Jill Beraud | Director | $166K | May 1, 2024 | ||
| Chris Nolet | Director | $166K | May 1, 2024 | ||
| Olivia C. Ware | Director | $120K | May 1, 2024 | ||
| Carey OConnor Kolaja | Director | $120K | May 1, 2024 | ||
| Vlad Coric | Director | $79K | May 1, 2024 | ||
| Philip J. Vickers | Director | May 4, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|